Home›Search›Expert Review of Clinical Pharmacology

Expert Review of Clinical Pharmacology

Taylor and Francis Ltd. · United Kingdom · Est. 1988

ISSN1751-2433eISSN1751-2441

SJR Q1✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (3 more)+18

Total96

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

days submission → published

measured · last 20 articles · accept 87d

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.848

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

1.016

Total Worksi

1,912

Total Citationsi

38,646

2yr Mean Citednessi

2.64

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope✦ Compiled from public sources

Expert Review of Clinical Pharmacology addresses the needs of clinical and pharmaceutical researchers, drug development specialists, and physicians. It covers challenges in modern biomedical practice and discusses trends affecting pharmaceutical markets.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1988

FrequencyAnnual

StatusActive (last: 2026)

Total Publications1,912

Publisher OrgTaylor & Francis

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Taylor and Francis Ltd.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1751-2433 / 1751-2441

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

114

3.4k

2019

130

2020

128

3.1k

2021

132

1.6k

2022

115

1.1k

2023

103

591

2024

163

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q1

Medicine (miscellaneous)Q2

Pharmacology (medical)Q2

Subject Classification

Web of Science Categories

Pharmacology & Pharmacy

Scopus Categories

Pharmacology (medical)Medicine (miscellaneous)Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Research Topics (OpenAlex)

Diabetes Treatment and ManagementHealth Systems, Economic Evaluations, Quality of LifePharmaceutical studies and practicesPharmacogenetics and Drug MetabolismPharmacological Effects and Toxicity StudiesPharmaceutical Practices and Patient OutcomesAntibiotics Pharmacokinetics and EfficacyAsthma and respiratory diseasesLipoproteins and Cardiovascular HealthPharmaceutical Economics and Policy

Frequently asked questions about Expert Review of Clinical Pharmacology

Is Expert Review of Clinical Pharmacology a predatory journal?

PubScope has no integrity flags on record for Expert Review of Clinical Pharmacology: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Expert Review of Clinical Pharmacology?

Expert Review of Clinical Pharmacology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.64.

Is Expert Review of Clinical Pharmacology indexed in Scopus and Web of Science?

Expert Review of Clinical Pharmacology is indexed in Web of Science, Scopus.